Photo of Mark McAndrew

Mark concentrates his practice on corporate, transactional and regulatory matters, counseling a wide variety of clients ranging from start-up entities to Fortune 500 companies, including technology companies, drug manufacturers, hospitals, physicians, pharmacies, and consumer product manufacturers, to name a few. He frequently serves as outside counsel for a number of these clients.

On Oct. 29, 2014, the United States Food and Drug Administration (FDA) held a webinar on its Final Guidance “Content of Premarket Submissions for Management of Cybersecurity in Medical Devices.” According to the FDA, the webinar seeks to explain the guidance and provide a forum for stakeholders to ask questions.

Issued on Oct. 2, 2014, the FDA’s cybersecurity guidance sets out a number of voluntary, non-binding recommendations designed to help medical device manufacturers identify relevant cybersecurity issues that should be
Continue Reading FDA Holds Webinar on Cybersecurity in Medical Devices Guidance